Dianthus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNTH and other ETFs, options, and stocks.About DNTH
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.
CEOMarino Garcia
CEOMarino Garcia
Employees78
Employees78
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2015
Founded2015
Employees78
Employees78
DNTH Key Statistics
Market cap1.92B
Market cap1.92B
Price-Earnings ratio-12.80
Price-Earnings ratio-12.80
Dividend yield—
Dividend yield—
Average volume683.07K
Average volume683.07K
High today$45.46
High today$45.46
Low today$43.28
Low today$43.28
Open price$43.72
Open price$43.72
Volume505.89K
Volume505.89K
52 Week high$45.46
52 Week high$45.46
52 Week low$13.37
52 Week low$13.37
Stock Snapshot
As of today, Dianthus Therapeutics(DNTH) shares are valued at $44.71. The company's market cap stands at 1.92B, with a P/E ratio of -12.80.
On 2025-12-05, Dianthus Therapeutics(DNTH) stock traded between a low of $43.28 and a high of $45.46. Shares are currently priced at $44.71, which is +3.3% above the low and -1.6% below the high.
The Dianthus Therapeutics(DNTH)'s current trading volume is 505.89K, compared to an average daily volume of 683.07K.
During the past year, Dianthus Therapeutics(DNTH) stock moved between $13.37 at its lowest and $45.46 at its peak.
During the past year, Dianthus Therapeutics(DNTH) stock moved between $13.37 at its lowest and $45.46 at its peak.
Analyst ratings
100%
of 15 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own DNTH. This list is generated using Robinhood data, and it’s not a recommendation.